Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC237535 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 142 |
0.1-0.2 | 10838 |
0.2-0.3 | 14260 |
0.3-0.4 | 5107 |
0.4-0.5 | 481 |
0.5-0.6 | 52 |
0.6-0.7 | 9 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC237535 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 111 |
0.1-0.2 | 1841 |
0.2-0.3 | 5428 |
0.3-0.4 | 1534 |
0.4-0.5 | 216 |
0.5-0.6 | 27 |
0.6-0.7 | 4 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6667 |
Remote Similarity |
NPD7155 |
Clinical (unspecified phase) |
0.6463 |
Remote Similarity |
NPD605 |
Clinical (unspecified phase) |
0.6275 |
Remote Similarity |
NPD6934 |
Discontinued |
0.6262 |
Remote Similarity |
NPD5359 |
Clinical (unspecified phase) |
0.587 |
Remote Similarity |
NPD1439 |
Clinical (unspecified phase) |
0.566
|
Remote Similarity |
NPD2682 |
Approved |